Neurogene Inc. (NASDAQ: NGNE) Stock Information | RedChip

Neurogene Inc. (NASDAQ: NGNE) Listen to this Section


$34.84
-0.7800 ( -2.19% ) 45.2K

Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.

Market Data


Open


$34.84

Previous close


$35.62

Volume


45.2K

Market cap


$455.04M

Day range


$34.50 - $36.92

52 week range


$12.49 - $53.00

Insider Ownership Transactions

Total Amount Purchased: 0.00 | $ 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Mar 18, 2024
10-k Annual reports 121 Mar 18, 2024
4 Insider transactions 1 Mar 14, 2024
4 Insider transactions 1 Mar 14, 2024
4 Insider transactions 1 Mar 14, 2024
8-k 8K-related 52 Mar 04, 2024
8-k 8K-related 14 Feb 21, 2024
3 Insider transactions 2 Jan 18, 2024
4 Insider transactions 2 Jan 18, 2024
4 Insider transactions 1 Jan 18, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.